FDA Adverse Event Malfunction Summary report: N

KYPHON HV-R BONE CEMENT

MDR report key: 9283593 · Received November 6, 2019

Report

Report Number
1030489-2019-01276
Event Type
Malfunction
Date Received
November 6, 2019
Date of Event
October 2, 2019
Report Date
November 6, 2019
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NDN
PMA / PMN Number
SEE H10
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS PART IS NOT APPROVED FOR USE IN THE UNITED STATES; HOWEVER A LIKE DEVICE CATALOG #: C01B, 510K #: K180700 AND UDI #: (B)(4) WAS CLEARED IN THE UNITED STATES. NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED PER A CLINICAL STUDY THAT THE PATIENT UNDERWENT VERTEBROPLASTY PROCEDURE AT L3/L4 LEVELS. DURING SURGERY, CEMENT EX TRAVASATION OCCURRED. NO PATIENT COMPLICATIONS WERE REPORTED DURING THIS EVENT. BONE CEMENT VOLUME IMPLANTED WAS 5 CC AND THE LOCATION OF EXTRAVASATION WAS FOUND TO BE AT THE INFERIOR DISK SPACE. CEMENT EXTRUSION WAS NOT GREATER THAN 15MM; AND WAS DETERMINED TO BE CLINICALLY INSIGNIFICANT. INVESTIGATOR NOTED THAT THE RELATEDNESS OF THE EVENT WAS PROCEDURE RELATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1081612 KYPHON HV-R BONE CEMENT CEMENT, BONE, VERTEBROPLASTY NDN MEDTRONIC SOFAMOR DANEK USA, INC NA 217996667

Patients

Seq Age Sex Outcome Treatment
1 55 YR